-+ 0.00%
-+ 0.00%
-+ 0.00%

Argus Research Maintains Buy on Merck & Co, Raises Price Target to $170

Benzinga·08/25/2026 12:58:02
語音播報
Argus Research analyst Jasper Hellweg maintains Merck & Co (NYSE:MRK) with a Buy and raises the price target from $145 to $170.